• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国风湿病学家对电子患者报告结局的接受度、使用情况和障碍:调查研究。

Acceptance, Usage, and Barriers of Electronic Patient-Reported Outcomes Among German Rheumatologists: Survey Study.

机构信息

Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin, Berlin, Germany.

Working Group Young Rheumatology, German Society for Rheumatology, Berlin, Germany.

出版信息

JMIR Mhealth Uhealth. 2020 Jul 20;8(7):e18117. doi: 10.2196/18117.

DOI:10.2196/18117
PMID:32390592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7400039/
Abstract

BACKGROUND

The use of patient-reported outcomes (PROs) allows for patient-centered, measurable, and transparent care. Electronic PROs (ePROs) have many benefits and hold great potential to improve current usage of PROs, yet limited evidence exists regarding their acceptance, usage, and barriers among rheumatologists.

OBJECTIVE

This study aims to evaluate the current level of acceptance, usage, and barriers among German rheumatologists regarding the use of ePROs. The importance of different ePRO features for rheumatologists was investigated. Additionally, the most frequently used PROs for patients with rheumatoid arthritis (RA) were identified.

METHODS

Data were collected via an online survey consisting of 18 questions. The survey was completed by members of the Working Group Young Rheumatology of the German Society for Rheumatology (Arbeitsgemeinschaft Junge Rheumatologie der Deutschen Gesellschaft für Rheumatologie [DGRh]) at the 2019 annual DGRh conference. Only members currently working in clinical adult rheumatology were eligible to complete the survey.

RESULTS

A total of 119 rheumatologists completed the survey, of which 107 (89.9%) reported collecting PROs in routine practice and 28 (25.5%) already used ePROs. Additionally, 44% (43/97) were planning to switch to ePROs in the near future. The most commonly cited reason for not switching was the unawareness of suitable software solutions. Respondents were asked to rate the features of ePROs on a scale of 0 to 100 (0=unimportant, 100=important). The most important features were automatic score calculation and display (mean 77.50) and simple data transfer to medical reports (mean 76.90). When asked about PROs in RA, the respondents listed pain, morning stiffness, and patient global assessment as the most frequently used PROs.

CONCLUSIONS

The potential of ePROs is widely seen and there is great interest in them. Despite this, only a minority of physicians use ePROs, and the main reason for not implementing them was cited as the unawareness of suitable software solutions. Developers, patients, and rheumatologists should work closely together to help realize the full potential of ePROs and ensure a seamless integration into clinical practice.

摘要

背景

使用患者报告的结果(PROs)可以实现以患者为中心、可衡量和透明的护理。电子患者报告结果(ePROs)具有许多优势,并且有很大的潜力可以改善当前 PROs 的使用,但关于风湿病学家对其接受程度、使用情况和障碍的证据有限。

目的

本研究旨在评估德国风湿病学家在使用电子患者报告结果方面的当前接受程度、使用情况和障碍。研究还调查了不同电子患者报告结果功能对风湿病学家的重要性。此外,还确定了类风湿关节炎(RA)患者最常使用的 PROs。

方法

通过一项在线调查收集数据,该调查由德国风湿病学会青年风湿病工作组(Arbeitsgemeinschaft Junge Rheumatologie der Deutschen Gesellschaft für Rheumatologie [DGRh])的成员在 2019 年 DGRh 年会上完成。只有目前在临床成人风湿病学领域工作的成员才有资格完成调查。

结果

共有 119 名风湿病学家完成了调查,其中 107 名(89.9%)报告在常规实践中收集 PROs,28 名(25.5%)已经使用电子患者报告结果。此外,44%(43/97)计划在不久的将来切换到电子患者报告结果。不切换的最常见原因是不知道合适的软件解决方案。受访者被要求对电子患者报告结果的功能进行评分,范围为 0 到 100(0=不重要,100=重要)。最重要的功能是自动评分计算和显示(平均值 77.50)和简单的数据传输到医疗报告(平均值 76.90)。当被问及 RA 中的 PROs 时,受访者列出疼痛、晨僵和患者整体评估作为最常使用的 PROs。

结论

电子患者报告结果的潜力被广泛认可,并且对此非常感兴趣。尽管如此,只有少数医生使用电子患者报告结果,不实施的主要原因是不知道合适的软件解决方案。开发人员、患者和风湿病学家应密切合作,以充分发挥电子患者报告结果的潜力,并确保其无缝融入临床实践。

相似文献

1
Acceptance, Usage, and Barriers of Electronic Patient-Reported Outcomes Among German Rheumatologists: Survey Study.德国风湿病学家对电子患者报告结局的接受度、使用情况和障碍:调查研究。
JMIR Mhealth Uhealth. 2020 Jul 20;8(7):e18117. doi: 10.2196/18117.
2
[Use of medical apps and online platforms among German rheumatologists : Results of the 2016 and 2018 DGRh conference surveys and research conducted by rheumadocs].德国风湿病学家对医学应用程序和在线平台的使用:2016年和2018年德国风湿病学会会议调查结果以及rheumadocs开展的研究
Z Rheumatol. 2019 Nov;78(9):839-846. doi: 10.1007/s00393-018-0578-3.
3
Patient motivators of postoperative electronic patient-reported outcome symptom monitoring use in thoracic surgery patients: a qualitative study.术后电子患者报告结局症状监测在胸外科患者中的使用:一项定性研究。
J Patient Rep Outcomes. 2024 Jul 25;8(1):81. doi: 10.1186/s41687-024-00766-0.
4
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey.COVID-19 时代的数字风湿病学:一项全国患者和医生调查结果。
RMD Open. 2021 Feb;7(1). doi: 10.1136/rmdopen-2020-001548.
5
Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities.头颈肿瘤学实践中电子患者报告结局作为护理标准整合的案例研究:障碍与机遇
Cancer. 2021 Feb 1;127(3):359-371. doi: 10.1002/cncr.33272. Epub 2020 Oct 27.
6
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.电子报告在癌症治疗期间脆弱且合并症较多的患者中的患者报告结局 - 一项可行性研究。
Health Qual Life Outcomes. 2020 Jul 11;18(1):225. doi: 10.1186/s12955-020-01480-3.
7
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.预测类风湿关节炎患者常规治疗中电子患者报告结局的反应:一项回顾性队列研究。
Rheumatol Int. 2023 Apr;43(4):651-657. doi: 10.1007/s00296-023-05278-6. Epub 2023 Jan 30.
8
Implementation of Electronic Patient-Reported Outcomes in Routine Cancer Care at an Academic Center: Identifying Opportunities and Challenges.在学术中心常规癌症护理中实施电子患者报告结局:确定机遇和挑战。
JCO Oncol Pract. 2020 Nov;16(11):e1255-e1263. doi: 10.1200/OP.20.00357. Epub 2020 Sep 14.
9
Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative study.数字化支持的以患者为中心的类风湿关节炎门诊随访 - 探索性定性研究。
BMC Health Serv Res. 2022 Oct 28;22(1):1297. doi: 10.1186/s12913-022-08619-6.
10
Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study.移动医疗的使用、偏好、障碍和风湿病患者的电子健康素养:患者调查研究。
JMIR Mhealth Uhealth. 2020 Aug 12;8(8):e19661. doi: 10.2196/19661.

引用本文的文献

1
Digital Transformation of Rheumatology Care in Germany: Cross-Sectional National Survey.德国风湿病护理的数字化转型:全国横断面调查
J Med Internet Res. 2025 Jan 6;27:e52601. doi: 10.2196/52601.
2
Rheumatology in the digital health era: status quo and quo vadis?数字健康时代的风湿病学:现状与未来走向?
Nat Rev Rheumatol. 2024 Dec;20(12):747-759. doi: 10.1038/s41584-024-01177-7. Epub 2024 Oct 31.
3
[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024].[德国的风湿病护理:德国风湿病与临床免疫学协会2024年备忘录]

本文引用的文献

1
Shared decision making in routine clinical care of patients with rheumatoid arthritis: an assessment of audio-recorded consultations.类风湿关节炎患者常规临床护理中的共同决策:对录音咨询的评估。
Ann Rheum Dis. 2020 Feb;79(2):170-175. doi: 10.1136/annrheumdis-2019-216137. Epub 2019 Oct 29.
2
Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study.使用生物传感器和患者报告结局数据对类风湿性关节炎进行纵向数字跟踪(DIGITAL):一项真实世界研究的方案
JMIR Res Protoc. 2019 Sep 26;8(9):e14665. doi: 10.2196/14665.
3
[Specialist training quo vadis?].
Z Rheumatol. 2024 Aug;83(Suppl 2):249-284. doi: 10.1007/s00393-024-01539-2. Epub 2024 Aug 13.
4
Awareness and intention-to-use of digital health applications, artificial intelligence and blockchain technology in breast cancer care.乳腺癌护理中数字健康应用程序、人工智能和区块链技术的认知度及使用意愿。
Front Med (Lausanne). 2024 May 2;11:1380940. doi: 10.3389/fmed.2024.1380940. eCollection 2024.
5
Remote monitoring of patients with rheumatoid arthritis in a low disease activity state: a mixed methods evaluation across six hospitals in London, UK.英国伦敦六家医院的类风湿关节炎低疾病活动度患者远程监测:混合方法评估。
Rheumatology (Oxford). 2024 Oct 1;63(10):2721-2733. doi: 10.1093/rheumatology/keae112.
6
Physician perspectives on chronic pain management: barriers and the use of eHealth in the COVID-19 era.医生对慢性疼痛管理的看法:COVID-19 时代的障碍和电子健康的使用。
BMC Health Serv Res. 2023 Oct 20;23(1):1131. doi: 10.1186/s12913-023-10157-8.
7
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study.预测类风湿关节炎患者常规治疗中电子患者报告结局的反应:一项回顾性队列研究。
Rheumatol Int. 2023 Apr;43(4):651-657. doi: 10.1007/s00296-023-05278-6. Epub 2023 Jan 30.
8
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience.一种用于在常规临床护理中实施健康相关生活质量测量的新型电子患者报告结局交付系统:五年经验分析
Front Digit Health. 2023 Jan 9;4:1074931. doi: 10.3389/fdgth.2022.1074931. eCollection 2022.
9
An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study.一种用于预测类风湿关节炎病情发作的人工智能临床决策支持系统:一项初步研究。
Diagnostics (Basel). 2023 Jan 1;13(1):148. doi: 10.3390/diagnostics13010148.
10
Factors Associated With Telemedicine Use Among German General Practitioners and Rheumatologists: Secondary Analysis of Data From a Nationwide Survey.德国全科医生和风湿病学家使用远程医疗的相关因素:一项全国性调查数据的二次分析。
J Med Internet Res. 2022 Nov 30;24(11):e40304. doi: 10.2196/40304.
[专科培训路在何方?]
Z Rheumatol. 2019 Oct;78(8):692-697. doi: 10.1007/s00393-019-00690-5.
4
German Mobile Apps in Rheumatology: Review and Analysis Using the Mobile Application Rating Scale (MARS).德国风湿病学移动应用程序:使用移动应用程序评级量表(MARS)进行的评估与分析。
JMIR Mhealth Uhealth. 2019 Aug 5;7(8):e14991. doi: 10.2196/14991.
5
Treat-to-target and shared decision making in rheumatoid arthritis treatment: Is it feasible?达标治疗与类风湿关节炎治疗中的共同决策:是否可行?
Int J Rheum Dis. 2019 Sep;22(9):1706-1713. doi: 10.1111/1756-185X.13664. Epub 2019 Jul 30.
6
Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice.在日常实践中评估类风湿关节炎患者的治疗达标概念实施情况。
Eur J Rheumatol. 2019 May 20;6(3):136-141. doi: 10.5152/eurjrheum.2019.18195. Print 2019 Jul.
7
Current Therapeutic Options in the Treatment of Rheumatoid Arthritis.类风湿关节炎治疗的当前治疗选择
J Clin Med. 2019 Jun 28;8(7):938. doi: 10.3390/jcm8070938.
8
Using Health Information Technology to Support Use of Patient-Reported Outcomes in Rheumatology.利用健康信息技术支持风湿病患者报告结局的应用。
Rheum Dis Clin North Am. 2019 May;45(2):257-273. doi: 10.1016/j.rdc.2019.01.007.
9
Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.在类风湿关节炎随机对照试验中使用每日电子患者报告结局(PRO)日记:基本原理与实施
Trials. 2019 Mar 22;20(1):182. doi: 10.1186/s13063-019-3272-0.
10
Treat-to-target in rheumatoid arthritis - are we there yet?类风湿关节炎的达标治疗——我们做到了吗?
Nat Rev Rheumatol. 2019 Mar;15(3):180-186. doi: 10.1038/s41584-019-0170-5.